Revvity Inc. $RVTY Stock Holdings Trimmed by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC lessened its holdings in shares of Revvity Inc. (NYSE:RVTY) by 39.8% in the third quarter, according to its most recent filing with the SEC. The firm owned 9,875 shares of the company’s stock after selling 6,535 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Revvity were worth $866,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of RVTY. AQR Capital Management LLC lifted its holdings in Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after purchasing an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Revvity by 6.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after buying an additional 744 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Revvity by 102.0% in the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after acquiring an additional 35,048 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after acquiring an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth increased its stake in shares of Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after acquiring an additional 811 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on RVTY shares. The Goldman Sachs Group started coverage on Revvity in a research note on Tuesday, December 9th. They set a “neutral” rating and a $105.00 price target for the company. Weiss Ratings restated a “sell (d)” rating on shares of Revvity in a report on Monday, December 29th. Robert W. Baird lifted their target price on Revvity from $122.00 to $123.00 and gave the stock an “outperform” rating in a report on Tuesday, October 28th. Evercore ISI reissued an “outperform” rating on shares of Revvity in a report on Monday, January 5th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $105.00 price objective on shares of Revvity in a research note on Monday. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $110.55.

Revvity Price Performance

NYSE RVTY opened at $106.98 on Tuesday. The company has a current ratio of 1.75, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 1 year low of $81.36 and a 1 year high of $126.57. The company has a market cap of $12.13 billion, a PE ratio of 53.76, a PEG ratio of 3.32 and a beta of 1.06. The stock’s 50-day moving average price is $104.09 and its two-hundred day moving average price is $95.52.

Revvity (NYSE:RVTY) last released its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The business had revenue of $772.06 million for the quarter, compared to the consensus estimate of $759.81 million. During the same period last year, the firm posted $1.42 earnings per share. The firm’s quarterly revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, analysts predict that Revvity Inc. will post 4.94 EPS for the current year.

Revvity announced that its Board of Directors has approved a share buyback program on Monday, October 27th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to purchase up to 8.7% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s dividend payout ratio (DPR) is 14.07%.

Key Headlines Impacting Revvity

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Q4 results beat expectations — adjusted EPS $1.70 (vs. consensus ~ $1.55) and revenue $772.1M, up 5.9% year-over-year, showing improving top- and bottom-line momentum. Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates
• Positive Sentiment: Company raised FY2026 guidance — EPS guidance of $5.35–$5.45 and ~ $3.0B revenue guidance that sit above Street estimates, signaling management confidence in diagnostics strength. Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter
• Positive Sentiment: Immediate market reaction was positive as investors pushed the stock higher on the beat + outlook, supported by analyst notes highlighting the upside. Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Management call/transcripts and slide deck are available — useful for investors wanting detail on segment trends, margin drivers and cadence of growth. Revvity (RVTY) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Valuation debate: recent share weakness has prompted DCF/analyst pieces arguing the stock may be attractive vs. intrinsic value, but opinions vary — this may support longer-term buyers more than short-term traders. Is Revvity (RVTY) Attractive After Recent Share Price Weakness And DCF Valuation Gap
• Negative Sentiment: Headwinds remain in academic research funding, which could pressure parts of the business even as diagnostics performs well — a risk to sustaining growth across all segments. Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.